Talk:Leronlimab

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
???	This article has not yet received a rating on the project's importance scale.

AIDS Low‑importance

	This article is part of WikiProject AIDS, an attempt to build a comprehensive, detailed, and accessible guide to AIDS, HIV, and related topics on Wikipedia. If you would like to participate in the project, you can choose to edit this article, or visit the project page for more information.AIDSWikipedia:WikiProject AIDSTemplate:WikiProject AIDSAIDS articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Leronlimab.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Too Many Primary Sources Cited for PRO 140, WP:PROMO and WP:PRIMARY Issues

Latest comment: 4 years ago1 comment1 person in discussion

just over half of the sources cited for our article PRO140 are WP:PRIMARY sources published by the drug's manufacturer CytoDyn.

Wikipedia's been seeing a rash of pharma firms seemingly using the project as a promotional vehicle for their products. See WP:PROMO for why you shouldn't do that.

Citing clinical trial data before endpoints are met and the study data submitted to FDA carries its own issues outside of Wikipedia.

Wikipedia editors ought to be vigiliant during the Covid-19 crisis not to allow our project to be used as a publicity vehicle for those who want to promote alleged cures for the pandemic. --loupgarous (talk) 16:06, 19 April 2020 (UTC)Reply

Add topic